Vitasora Health Management
Management criteria checks 4/4
Vitasora Health's CEO is Marjan Mikel, appointed in Dec 2019, has a tenure of 6.42 years. total yearly compensation is A$511.25K, comprised of 83.8% salary and 16.2% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth A$131.51K. The average tenure of the management team and the board of directors is 5.5 years and 3.3 years respectively.
Key information
Marjan Mikel
Chief executive officer
AU$511.2k
Total compensation
| CEO salary percentage | 83.78% |
| CEO tenure | 6.4yrs |
| CEO ownership | 0.5% |
| Management average tenure | 5.5yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | -AU$12m |
| Sep 30 2025 | n/a | n/a | -AU$11m |
| Jun 30 2025 | AU$511k | AU$428k | -AU$10m |
| Mar 31 2025 | n/a | n/a | -AU$9m |
| Dec 31 2024 | n/a | n/a | -AU$8m |
| Sep 30 2024 | n/a | n/a | -AU$7m |
| Jun 30 2024 | AU$758k | AU$428k | -AU$7m |
| Mar 31 2024 | n/a | n/a | -AU$7m |
| Dec 31 2023 | n/a | n/a | -AU$6m |
| Sep 30 2023 | n/a | n/a | -AU$6m |
| Jun 30 2023 | AU$570k | AU$428k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$6m |
| Sep 30 2022 | n/a | n/a | -AU$6m |
| Jun 30 2022 | AU$607k | AU$428k | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$8m |
| Sep 30 2021 | n/a | n/a | -AU$9m |
| Jun 30 2021 | AU$2m | AU$428k | -AU$11m |
| Mar 31 2021 | n/a | n/a | -AU$12m |
| Dec 31 2020 | n/a | n/a | -AU$12m |
| Sep 30 2020 | n/a | n/a | -AU$10m |
| Jun 30 2020 | AU$2m | AU$187k | -AU$7m |
Compensation vs Market: Marjan's total compensation ($USD363.72K) is about average for companies of similar size in the Australian market ($USD329.82K).
Compensation vs Earnings: Marjan's compensation has been consistent with company performance over the past year.
CEO
Marjan Mikel
Mr. Marjan Mikel, M.Com, BSc (Hons), Dip Ed, MAICD), has been Independent Non-Executive Director of Memphasys Limited since June 19, 2025. He serves as Chief Executive Officer and Managing Director at Vita...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 6.6yrs | AU$245.46k | 1.06% A$ 307.0k | |
| CEO, MD & Executive Director | 6.4yrs | AU$511.25k | 0.45% A$ 131.5k | |
| Chief Operations Officer | 5.5yrs | AU$288.11k | no data | |
| Chief Research Officer | 7.3yrs | AU$195.23k | no data | |
| Head of US Operations & Chief Commercial Officer for the US market | 3.1yrs | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data | |
| Medical & Scientific Advisor | no data | AU$310.61k | no data | |
| Medical & Scientific Advisor | no data | no data | no data |
Experienced Management: VHL's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 6.6yrs | AU$245.46k | 1.06% A$ 307.0k | |
| CEO, MD & Executive Director | 6.5yrs | AU$511.25k | 0.45% A$ 131.5k | |
| Member of Medical Advisory Board | 3.3yrs | no data | no data | |
| Chair of Medical Advisory Board | 3.3yrs | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | AU$1.47k | no data | |
| Member of Medical Advisory Board | 3.3yrs | no data | no data | |
| Member of Medical Advisory Board | 3.3yrs | no data | no data | |
| Non-Executive Director | 1.3yrs | no data | no data |
Experienced Board: VHL's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/19 18:00 |
| End of Day Share Price | 2026/05/19 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vitasora Health Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Soo Romanoff | Edison Investment Research |
| Andrew Goodsall | MST Financial Services Pty Limited |
| Rita Fung | MST Financial Services Pty Limited |